Daxor Market Cap 2010-2011 | DXR

Daxor market cap history and chart from 2010 to 2011. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Daxor market cap as of August 15, 2025 is $0.05B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.051B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.954B 19.06
Encompass Health (EHC) United States $12.052B 24.07
DaVita (DVA) United States $9.609B 13.74
Elanco Animal Health (ELAN) United States $8.943B 20.00
Chemed (CHE) United States $6.468B 21.66
RadNet (RDNT) United States $5.288B 190.97
Option Care Health (OPCH) United States $4.611B 19.73
Amedisys (AMED) United States $3.321B 21.26
LifeStance Health (LFST) United States $2.170B 0.00
Addus HomeCare (ADUS) United States $2.096B 22.59
Astrana Health (ASTH) United States $1.656B 57.92
Aveanna Healthcare Holdings (AVAH) United States $1.504B 27.69
U.S Physical Therapy (USPH) United States $1.307B 32.69
Pennant (PNTG) United States $0.854B 30.12
Atai Life Sciences (ATAI) Germany $0.803B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.064B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00